XML 19 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities    
Net income $ 80,128 $ 47,083
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 42,499 31,206
Deferred income taxes 318 (3,549)
Loss from discontinued operations 408 771
Restructuring charges 817 3,664
Impairment charges (recoveries) (29,098) 120
Gains on dispositions of property and other assets 465 126
Share-based compensation expense 9,484 4,709
Excess tax benefit from share-based compensation arrangements   (60)
Other non-cash items, net 3,603 4,644
Change in operating assets and liabilities (excluding the impact of acquisitions):    
Receivables (25,966) (41,510)
Inventories (6,839) (12,903)
Accounts payable 18,998 38,522
Restructuring liabilities (1,748) (2,518)
Accrued compensation (7,455) (620)
Customer deposits 9,076 26,954
Income taxes payable 16,058 5,280
Other assets and liabilities, net 3,895 13,503
Net cash provided by operating activities 114,643 115,422
Cash flows from investing activities    
Capital expenditures (39,493) (32,582)
Proceeds from insurance 31,570  
Cash paid for acquired businesses, net (1,661) (145,735)
Proceeds from dispositions of property and other assets 734 774
Net cash used in investing activities (8,850) (177,543)
Cash flows from financing activities    
Proceeds from borrowings 60,574 153,000
Payments on debt and capital lease obligations (128,808) (86,989)
Dividends paid on common stock (6,119) (6,079)
Debt issuance costs (5) (340)
Common stock purchased for treasury (1,272) (679)
Excess tax benefit from share-based compensation arrangements   60
Net cash provided by (used in) financing activities (75,630) 58,973
Effect of exchange rate changes on cash and cash equivalents 2,418 (702)
Net change in cash and cash equivalents 32,581 (3,850)
Cash and cash equivalents, beginning of year 20,900 56,531
Cash and cash equivalents, end of period $ 53,481 $ 52,681